In this translational breast cancer trial, we investigated the effect of short-term, high-dose atorvastatin treatment on intratumoral cholesterol homeostasis, regarding the expression of LDLR and tumor tissue cholesterol levels. This evidence concerns the gene LDLR and breast cancer.